286 related articles for article (PubMed ID: 22368277)
1. Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.
Gulati S; Agarwal S; Vasudhev S; Rice PA; Ram S
J Immunol; 2012 Apr; 188(7):3416-25. PubMed ID: 22368277
[TBL] [Abstract][Full Text] [Related]
2. Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.
Gulati S; Beurskens FJ; de Kreuk BJ; Roza M; Zheng B; DeOliveira RB; Shaughnessy J; Nowak NA; Taylor RP; Botto M; He X; Ingalls RR; Woodruff TM; Song WC; Schuurman J; Rice PA; Ram S
PLoS Biol; 2019 Jun; 17(6):e3000323. PubMed ID: 31216278
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
[TBL] [Abstract][Full Text] [Related]
4. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
[TBL] [Abstract][Full Text] [Related]
5. Lysis of Neisseria gonorrhoeae initiated by binding of normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strain-specific, properdin-binding-dependent alternative complement pathway activation.
Griffiss JM; Jarvis GA; O'Brien JP; Eads MM; Schneider H
J Immunol; 1991 Jul; 147(1):298-305. PubMed ID: 1711080
[TBL] [Abstract][Full Text] [Related]
6. Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing.
Lewis LA; Shafer WM; Dutta Ray T; Ram S; Rice PA
Infect Immun; 2013 Jan; 81(1):33-42. PubMed ID: 23071134
[TBL] [Abstract][Full Text] [Related]
7. Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.
Ngampasutadol J; Ram S; Blom AM; Jarva H; Jerse AE; Lien E; Goguen J; Gulati S; Rice PA
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17142-7. PubMed ID: 16275906
[TBL] [Abstract][Full Text] [Related]
8. Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance.
Ram S; Ngampasutadol J; Cox AD; Blom AM; Lewis LA; St Michael F; Stupak J; Gulati S; Rice PA
Infect Immun; 2007 Aug; 75(8):4071-81. PubMed ID: 17526744
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids.
Gulati S; McQuillen DP; Mandrell RE; Jani DB; Rice PA
J Infect Dis; 1996 Dec; 174(6):1223-37. PubMed ID: 8940213
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.
Agarwal S; Ferreira VP; Cortes C; Pangburn MK; Rice PA; Ram S
J Immunol; 2010 Jul; 185(1):507-16. PubMed ID: 20530262
[TBL] [Abstract][Full Text] [Related]
11. C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae.
Ram S; Cullinane M; Blom AM; Gulati S; McQuillen DP; Boden R; Monks BG; O'Connell C; Elkins C; Pangburn MK; Dahlbäck B; Rice PA
Int Immunopharmacol; 2001 Mar; 1(3):423-32. PubMed ID: 11367527
[TBL] [Abstract][Full Text] [Related]
12. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae.
Ram S; Cullinane M; Blom AM; Gulati S; McQuillen DP; Monks BG; O'Connell C; Boden R; Elkins C; Pangburn MK; Dahlbäck B; Rice PA
J Exp Med; 2001 Feb; 193(3):281-95. PubMed ID: 11157049
[TBL] [Abstract][Full Text] [Related]
13. Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.
Chakraborti S; Lewis LA; Cox AD; St Michael F; Li J; Rice PA; Ram S
J Immunol; 2016 Jun; 196(11):4576-86. PubMed ID: 27183633
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the interaction between porins of Neisseria gonorrhoeae and C4b-binding protein.
Jarva H; Ngampasutadol J; Ram S; Rice PA; Villoutreix BO; Blom AM
J Immunol; 2007 Jul; 179(1):540-7. PubMed ID: 17579075
[TBL] [Abstract][Full Text] [Related]
15. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
[TBL] [Abstract][Full Text] [Related]
16. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.
Ram S; Mackinnon FG; Gulati S; McQuillen DP; Vogel U; Frosch M; Elkins C; Guttormsen HK; Wetzler LM; Oppermann M; Pangburn MK; Rice PA
Mol Immunol; 1999; 36(13-14):915-28. PubMed ID: 10698346
[TBL] [Abstract][Full Text] [Related]
17. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
18. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S; Shaughnessy J; Ram S; Rice PA
Front Immunol; 2019; 10():321. PubMed ID: 30873172
[TBL] [Abstract][Full Text] [Related]
19. Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.
Chakraborti S; Gulati S; Zheng B; Beurskens FJ; Schuurman J; Rice PA; Ram S
Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31818965
[TBL] [Abstract][Full Text] [Related]
20. Structural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epitopes.
Yamasaki R; Koshino H; Kurono S; Nishinaka Y; McQuillen DP; Kume A; Gulati S; Rice PA
J Biol Chem; 1999 Dec; 274(51):36550-8. PubMed ID: 10593954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
